بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant bins » significant bias (توسيع البحث), significant bit (توسيع البحث), significant hits (توسيع البحث)
bins decrease » point decrease (توسيع البحث), sizes decrease (توسيع البحث), nn decrease (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant bins » significant bias (توسيع البحث), significant bit (توسيع البحث), significant hits (توسيع البحث)
bins decrease » point decrease (توسيع البحث), sizes decrease (توسيع البحث), nn decrease (توسيع البحث)
-
601
Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
602
Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
603
Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
604
Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
605
Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
606
Additional file 3 of Single-cell profiling reveals a reduced epithelial defense system, decreased immune responses and the immune regulatory roles of different fibroblast subpopula...
منشور في 2025"…P values were calculated via the two-sided Wilcoxon test. ns, not significant, **, P < 0.01 and ****, P < 0.0001. (G) Feature plot showing LDLR expression levels in C1Q+ macrophages between CAG and control samples.…"
-
607
-
608
Data Sheet 1_Secretoneurin plasma levels are decreased after catheter ablation for atrial fibrillation—patients with AF produce lower SN levels than healthy individuals: the SAFE r...
منشور في 2025"…Plasma SN levels were significantly lower after the catheter ablation as compared with SN levels before (34.0 ± 15.1 and 40.0 ± 17.3 pmol/L, p = 0.032). …"
-
609
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin...
منشور في 2025"…The substantial and differential decrease in testosterone and SHBG levels does not explain our previous finding of no detected decrease in risky sexual behavior or sexual function for DMPA-IM or NET-EN users from D0 to 25W. …"
-
610
-
611
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
منشور في 2025الموضوعات: -
612
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
منشور في 2025الموضوعات: -
613
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
منشور في 2025الموضوعات: -
614
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
منشور في 2025الموضوعات: -
615
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
منشور في 2025الموضوعات: -
616
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
منشور في 2025الموضوعات: -
617
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
منشور في 2025الموضوعات: -
618
-
619
-
620